Elevated levels of Mir-15B are transferred from arsenite-treated THP-1 (AS-THP-1) cells to HCC cells via Mir-15b in EVs, inhibit Hippo pathway activation by targeting LATS1, and participate in the migration and invasion of proliferation-promoting HCC cells. Here, LATS1 is linked to hepatocellular carcinoma.